Literature DB >> 25946735

The risk of prostate cancer in pilots: a meta-analysis.

David Raslau, Douglas T Summerfield, Abd M Abu Dabrh, Lawrence W Steinkraus, Mohammad H Murad.   

Abstract

BACKGROUND: Aviation exposes pilots to various occupationally related hazards, including ionizing radiation and chemical combustion. The possible increased risk of prostate cancer among pilots in comparison to the general population is a subject of debate. This systematic review and meta-analysis aimed to determine the quality of supporting evidence and magnitude of this association.
METHODS: All studies pertaining to prostate cancer in pilots were retrieved from multiple databases and from a manual search. Any study that assessed the incidence of prostate cancer relative to the incidence in the general population was included regardless of language or size. A random effect model was used to pool relative risks (RR) across studies. Heterogeneity was assessed using the Q statistic and I².
RESULTS: Eight studies with a low risk of bias were included in the meta-analysis. Pilots had an increased risk of developing prostate cancer compared to the general population [RR 2.0; 95% confidence interval (CI), 1.5-2.7]. The analysis was associated with substantial heterogeneity (I² = 79%). Several subgroups had significantly increased risk, such as African American pilots (RR 10.00; 95% CI, 5.04-19.86) and military pilots (RR 3.30; 95% CI, 2.03-5.39).
CONCLUSION: Pilots are at least twice as likely to develop prostate cancer compared to the general population. The implications of these findings are important considering the high prevalence of prostate cancer and the large number of pilots in the workforce.

Entities:  

Mesh:

Year:  2015        PMID: 25946735     DOI: 10.3357/AMHP.4075.2015

Source DB:  PubMed          Journal:  Aerosp Med Hum Perform        ISSN: 2375-6314            Impact factor:   1.053


  1 in total

Review 1.  Seven sins in publishing (but who's counting…).

Authors:  P J Benson
Journal:  Ann R Coll Surg Engl       Date:  2016-01       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.